ADHD Titration Phases: Initiation, Adjustment, Maintenance

"We'll start you low and titrate up." Your prescriber said it, you nodded, and then you walked out of the appointment with a prescription and almost no information about what the next three months would actually feel like. The word "titration" gets used as if it explains something, but for most newly diagnosed adults, the ADHD titration phases are completely opaque — you don't know when a side effect is expected, when it means your dose is wrong, or when you've reached the point where the medication is doing what it's supposed to.

This is a plain-language breakdown of what each phase looks like, what's normal within it, and what to track so you're not flying blind.

What Titration Actually Means

Titration isn't just "starting on a low dose." It's a structured process of finding the minimum effective dose — the amount that gives you consistent benefit with the fewest side effects.

For stimulant medications (Vyvanse, Adderall, Concerta, Ritalin), this matters because the therapeutic window is individual. Two people with the same diagnosis and the same medication can have wildly different responses to the same milligram dose. Your genetics, your weight, how your liver metabolizes amphetamines or methylphenidate, your sleep, your diet — all of it affects the result.

That's why prescribers start low. Not because low doses are expected to work, but because they need a baseline from which to observe your response before moving up. Each adjustment is a data point. The question your prescriber is answering across the first 60 to 90 days is: at what dose do you get the most benefit with the least cost?

You can't answer that question from memory. And you can't answer it from a few sentences at a follow-up appointment. Which is why tracking across each phase matters.

Phase 1 — Initiation (Days 1–14)

The Initiation phase covers your first two weeks on medication. This is the new-to-stimulants window, and it has its own characteristic pattern that's worth knowing in advance.

What's normal in this phase:

- Appetite suppression. Most stimulants reduce appetite, especially in the first weeks. This typically moderates as your body adjusts.
- Sleep changes. Earlier bedtimes or difficulty falling asleep are common, particularly if the dose is taken late in the morning.
- Hyperfocus bursts. Early on, the medication may feel like it works intensely in narrow windows. This often smooths out as titration continues.
- Afternoon fatigue. As the medication wears off, a dip in energy — sometimes called the "rebound" — is common. It's often most pronounced in weeks one and two.
- Mild headaches. Especially in the first few days. Usually dehydration-related. Drink more water than you think you need.

What to track in Initiation:

This is your baseline period. What you log in days 1–14 becomes the reference point your prescriber uses to evaluate whether a dose adjustment is working. Log every day if you can — even short entries. The goal is capturing what starting looks like for you specifically.

Focus on: exact dose and time taken, whether you took it with food, focus and energy levels mid-morning and mid-afternoon, any side effects with specifics (not "headache" but "mild headache, 2–3pm, gone by 5pm"), and sleep quality that night.

Inconsistent tracking in Initiation means your prescriber is guessing at your baseline. Consistent tracking means they're working from evidence.

Phase 2 — Adjustment (Days 15–45)

If week two ends and the dose isn't clearly working — or the side effects aren't manageable — your prescriber will typically adjust. This is the Adjustment phase. Most dose changes happen here, and it's the most variable stretch of titration.

What's normal in this phase:

- Variable response across days. You may notice the medication working well one day and flat the next. This is normal during dose changes and as your body adapts to a new level.
- The "good day" trap. One excellent day at a new dose doesn't mean you've found your level. One bad day doesn't mean the dose is wrong. Patterns across a week are what matter.
- Re-emergence of early side effects. If your dose increases, some first-week symptoms (appetite suppression, sleep disruption) may return briefly at the new level before stabilizing.

What to track in Adjustment:

The data that matters most here is dose-response correlation. When your prescriber changes your dose, you need to be able to report: at 20mg, my focus averaged 3/5 and I had daily afternoon fatigue. At 30mg, focus improved to 4/5 and fatigue reduced. That kind of structured comparison is what allows targeted adjustments.

If you're only logging on days that feel notable, you'll miss the pattern. Track every day — including the ordinary ones — because the signal is in the trend, not the outliers.

Phase 3 — Maintenance (Days 46–90)

Maintenance begins when your prescriber has found a dose that's working and stable. The goal shifts from finding the right level to confirming it holds.

What's normal in this phase:

- Consistency. Days should start to feel more predictable. If they don't — if you're still getting strong variation day to day — that's useful data, not a sign to stop tracking.
- Refinement conversations. Some people find that their dose needs minor adjustments as the months go on. Timing of the dose, whether to add an afternoon booster, whether a different formulation works better — these conversations happen in Maintenance.
- Identity adjustment. This phase is often when people start processing what ADHD-medicated life actually feels like versus what they expected. The clinical and the personal overlap here.

What to track in Maintenance:

Less urgency than Initiation, but continued value. The weekly PDF you hand your psychiatrist at a three-month follow-up — showing consistent focus and energy trends, reduced side effects, stable sleep — is what good maintenance data looks like. It closes the loop on the titration process and gives your prescriber confidence that the current protocol is right.

When to Contact Your Prescriber Between Appointments

The ADHD titration phases are a framework, not a guarantee. Some side effects warrant contact before your scheduled follow-up:

- Chest pain or significantly elevated heart rate
- Severe mood episodes — especially agitation, rage, or a flatness that feels like depression
- Thoughts of self-harm
- Complete inability to sleep for multiple consecutive nights

These aren't standard titration effects. Document them and call your prescriber's office the same day.

---

Calibrate is built around this three-phase model. The 90-day arc in the app maps directly to Initiation, Adjustment, and Maintenance — with phase-transition guidance at day 14 and day 45 so you know what to expect before you're in it. The weekly clinician PDF packages your logged data into something your prescriber can actually use, so every appointment starts from evidence rather than recollection.

If you're in the early weeks and trying to make sense of how the ADHD titration phases apply to your specific experience, Calibrate gives you the structure to track it and the format to communicate it.